Study of weight-loss medication effects on body composition
Part of Hormones & metabolism clinical trials.
This trial looks at how two weight-loss medications, semaglutide and tirzepatide, affect your body's fat and muscle. It may help you understand if these medications improve your overall health beyond just weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting treatment with semaglutide or tirzepatide through the Vineyard Virtual Health Clinic
- Your body mass index (BMI) is 30 or higher, OR your BMI is 27 or higher and you have at least one other health problem like high blood pressure or high cholesterol
- You live within driving distance of a city that has a DXA scanner (a special X-ray machine that measures body fat and muscle) and you are willing to go there for regular body scans
- You do NOT have type 2 diabetes
- You are not currently pregnant or trying to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This study looks at how weight loss medications (semaglutide or tirzepatide) affect your appetite and the hormones that control it. The goal is to better understand why these medicines help people lose weight.
This trial tests two different weight-loss medications (semaglutide and tirzepatide) taken alongside exercise to help people with obesity. It aims to see which approach works better for weight loss and overall health.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.